dalteparin has been researched along with Tonsillitis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Tonsillitis: Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akram, J | 1 |
| Josefsson, P | 1 |
| Rømeling, F | 1 |
1 other study available for dalteparin and Tonsillitis
| Article | Year |
|---|---|
[Necrotizing tonsillitis and renal vein thrombosis due to acute myeloid leukaemia].
Topics: Adult; Antineoplastic Agents; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Le | 2012 |